Speakers

Keynote Speakers ------- Executive Panel ------- Breakout Sessions

 

The Executive Panel consists of 4 professionals from various sectors of the healthcare industry that will debate the merits of the consumer/patient as the central stakeholder in healthcare. The panel will begin to dissect the conference theme into its component pieces and will create debate and discussion that can be carried into the breakout sessions.

ROBERT Galvin, MD

Director of Global Healthcare, General Electric
Executive Panel Moderator

Robert Galvin, MD, is Director of Global Healthcare for General Electric (GE). In addition to responsibility for the corporation's $3B annual health spend, he oversees the GE clinical group, encompassing over 215 clinics in 30 countries and leads health policy for the corporation. In his current role Dr. Galvin has focused on issues of market-based health policy and financing, with special interest in performance measurement, payment reform, and the assessment and
coverage of new technologies. He is a co-founder of The Leapfrog Group and the founder of Bridges to Excellence. He is on the Board of Directors of the National Committee for Quality Assurance and is a member of the Commonwealth Fund�s Commission on a High Performance Health System. He has also served on several Institute of Medicine Committees.

The work of Dr. Galvin has received awards from the National Health Care Purchasing Institute, The National Business Group on Health and the National Coalition for Cancer Survivorship. He is a Fellow of the American College of Physicians, and his work has been published in the New England Journal of Medicine and Health Affairs. He is a Professor Adjunct of Medicine at Yale where he leads the Robert Wood Johnson Clinical Scholar seminar series on the private sector.

 

Robert Graham, MD

Professor of Family Medicine, University of Cincinnati School of Medicine
Executive Panelist

Dr. Graham currently is Professor of Family Medicine, and the Robert and Myfanwy Smith Chair in the Department of Family Medicine at the University of Cincinnati, School of Medicine, a position he has held since March of 2005.

Dr. Graham has previously been associated with the discipline of Family Medicine as the Executive Vice President/CEO of the American Academy of Family Physicians (AAFP) (1985-2000), the head of the Academy�s Foundation (1988-1997), and the Administrative Officer of the Society of Teachers of Family Medicine (STFM) (1973-1975).

In addition to his activities in Family Medicine, Dr. Graham has held a number of leadership responsibilities in the Federal Health Sector, including the position of Administrator of the Health Resources and Services Administration (HRSA) (1981-1985), during which time he held the rank of Rear Admiral in the Commissioned Corps of the U.S. Public Health Service, and served as an Assistant Surgeon General. He also served in senior positions at the Agency for Healthcare Research and Quality (2001-2004), the Health Resources Administration (1976-1979), and the Health Services and Mental Health Administration (1970-1973). From 1979-1980, he served as a Professional Staff Member of the U.S. Senate Sub-committee on Health.

Dr. Graham, a native of Kansas, is a graduate of Earlham College, Richmond, Indiana (1965), and the University of Kansas School of Medicine in Kansas City, Kansas (1970).

 

Jeffrey Kang, MD, MPH

Chief Medical Officer, Cigna Healthcare
Executive Panelist

Dr. Jeffrey Kang is the Chief Medical Officer of CIGNA. Prior to joining CIGNA HealthCare, Dr. Kang worked at the federal Centers for Medicare and Medicaid Services (CMS, previously the Health Care Financing Administration) in a variety of capacities, most recently as Chief Clinical Officer. In his career at CMS, Kang spearheaded the national quality improvement program through Medicare's Quality Improvement Organizations. Dr. Kang served on the Quality Forum Planning Committee, convened in 1998 by then - Vice President Al Gore to propose a basic governance and operating structure for NQF. In addition to his responsibilities as the chief medical officer for CIGNA HealthCare, Dr. Kang also co-chairs NQF's Steering Committee on Standardizing Ambulatory Care Performance Measures. He also serves on the Institute of Medicine's Subcommittee on Quality Improvement Organization Evaluation and is a board member of the eHealth Initiative.

Board-certified in internal medicine and geriatrics, Dr. Kang holds a B.A. from Harvard College, received his M.D. from the University of California at San Francisco, and a Masters in Public Health from the University of California at Berkeley.

 

Arthur A. Levin, MPH

Director, Center for Medical Consumers
Executive Panelist

Arthur A. Levin, MPH, serves as the consumer representative on the FDA Drug Safety and Risk Management Advisory Committee; is the only consumer member of the NY State Department of Health workgroup, which has completely overhauled the system of reporting and tracking adverse events in New York State hospitals; has long been a member of the FDA Nominating Group that is responsible for nominating consumer representatives to FDA advisory committees; is a member of the Patients and Consumers Coalition of advocates who oppose efforts to weaken the FDA through deregulation; and was the only consumer member to serve on the Institute of Medicine's Committee on the Quality of Health Care in America, which issued the landmark report To Err is Human that garnered international attention for its depiction of medical errors as a leading cause of preventable death and injury in the U.S.

 

Lambert van der Walde

Capital Markets Advisor to the Administrator, Centers for Medicare & Medicaid Services
Executive Panelist

Lambert van der Walde is the Capital Markets Advisor to the Administrator of the Centers for Medicare & Medicaid Services (CMS, formerly the Health Care Financing Administration). CMS plays a key role in the overall direction of the U.S. health care system. With a budget of approximately $650 billion and serving over 90 million beneficiaries in the Medicare, Medicaid, and SCHIP programs, CMS is the largest purchaser of health care in the world.

Lambert directs CMS capital markets efforts, which include advising the CMS Administrator and other administration officials of expected and actual market consequences of new and proposed regulatory and legislative actions as well as health care industry market performance, access to capital, and financial outlook.

Lambert also serves as the CMS point-of-contact for the investor community as the liaison between policy makers, the investor community, and the health care industry. He speaks on a regular basis to investor and industry groups, provides explanation and interpretation of government health care policy and processes to research analysts and investors, and develops strategic relationships with leaders in the health care industry and the financial markets.

Prior to serving the Bush Administration, Lambert worked for Salomon Smith Barney�s Investment Banking Division where he focused on equity and debt underwriting as well as mergers and acquisitions advisory services. Lambert has also worked in venture capital financing and other sectors of the financial services industry.

Lambert holds a B.A. from the University of Washington and an MBA from the Wharton School of the University of Pennsylvania.